Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo

被引:108
|
作者
Riu, Efren
Chen, Zhi-Ying
Xu, Hui
He, Chen-Yi
Kay, Mark A.
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
关键词
D O I
10.1038/sj.mt.6300177
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
One of the major obstacles to success in non-viral gene therapy is transcriptional silencing of the DNA vector. The mechanisms underlying gene silencing/repression in mammalian cells are complex and remain unclear. Because changes in chromatin structure and, in particular, histone modifications are involved in transcriptional regulation of endogenous genes, we hypothesized that changes in the pattern of histone modifications were related to the observed transcriptional silencing of exogenous DNA vectors. We used antibodies against specific modified histones to perform chromatin immunoprecipitation (ChIP) analyses on liver lysates from mice transfected with two types of plasmids: (i) DNA minicircles (MCs) devoid of bacterial plasmid backbone DNA, which showed marked persistence of transgene expression, and (ii) their parental plasmids, which were silenced over time. Silencing of the transgene from the parental vectors was accompanied by an increase in heterochromatin-associated histone modifications and a decrease in modifications typically associated with euchromatin. Conversely, the pattern of histone modifications on the MC DNA was consistent with euchromatin. Our data indicates that (i) episomal vectors undergo chromatinization in vivo, and (ii) both persistence and silencing of transgene expression are associated with specific histone modifications.
引用
收藏
页码:1348 / 1355
页数:8
相关论文
共 50 条
  • [1] Sendai virus vector-mediated transgene expression in the cochlea in vivo
    Kanzaki, Sho
    Shiotani, Akihiro
    Inoue, Makoto
    Hasegawa, Mamoru
    Ogawa, Kaoru
    [J]. AUDIOLOGY AND NEURO-OTOLOGY, 2007, 12 (02): : 119 - 126
  • [2] Vector-Mediated In Vivo Antibody Expression
    Schnepp, Bruce C.
    Johnson, Philip R.
    [J]. MICROBIOLOGY SPECTRUM, 2014, 2 (04):
  • [3] The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo
    Tan, YD
    Li, S
    Pitt, BR
    Huang, L
    [J]. HUMAN GENE THERAPY, 1999, 10 (13) : 2153 - 2161
  • [4] Pristimerin Enhances Recombinant Adeno-Associated Virus Serotype 2 Vector-Mediated Transgene Expression Both In Vitro and In Vivo
    Wang, Lina
    Wang, Yuan
    Aslanidi, George V.
    Srivastava, Arun
    Ling, Changquan
    Ling, Chen
    [J]. MOLECULAR THERAPY, 2013, 21 : S121 - S121
  • [5] Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro
    Candolfi, Marianela
    Pluhar, G. Elizabeth
    Kroeger, Kurt
    Puntel, Mariana
    Curtin, James
    Barcia, Carlos
    Muhammad, A. K. M. Ghulam
    Xiong, Weidong
    Liu, Chunyan
    Mondkar, Sonali
    Kuoy, William
    Kang, Terry
    McNeil, Elizabeth A.
    Freese, Andrew B.
    Ohlfest, John R.
    Moore, Peter
    Palmer, Donna
    Ng, Phillip
    Young, John D.
    Lowenstein, Pedro R.
    Castro, Maria G.
    [J]. NEURO-ONCOLOGY, 2007, 9 (03) : 245 - 258
  • [6] The Inhibitory Effect of Various Transfection Agents on rAAV Vector-Mediated Transgene Expression Both In Vitro and In Vivo
    Wang, Yuan
    Wang, Lina
    Aslanidi, George V.
    Ling, Changquan
    Srivastava, Arun
    Ling, Chen
    [J]. MOLECULAR THERAPY, 2014, 22 : S117 - S117
  • [7] Alterations of histone modifications and transgene silencing by nickel chloride
    Ke, Qingdong
    Davidson, Todd
    Chen, Haobin
    Kluz, Thomas
    Costa, Max
    [J]. CARCINOGENESIS, 2006, 27 (07) : 1481 - 1488
  • [8] Activation of the CMV Promoter: Considerations for Viral Vector-Mediated Transgene Expression
    Howard, Doug
    Back, Susanne
    Dossat, Amanda
    Chen, Yun-Hsiang
    Wang, Yun
    Harvey, Brandon K.
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 161 - 161
  • [9] Single-polarity recombinant adeno-associated virus 2 vector-mediated transgene expression in vitro and in vivo:: Mechanism of transduction
    Zhong, Li
    Zhou, Xiaohuai
    Li, Yanjun
    Qing, Keyun
    Xiao, Xiao
    Samulski, Richard Jude
    Srivastava, Arun
    [J]. MOLECULAR THERAPY, 2008, 16 (02) : 290 - 295
  • [10] The Murine Dystrophic Muscle Environment Reduces Adeno-Associated Virus Vector-mediated Transgene Expression
    Dupont, Jean-Baptiste
    Leger, Adrien
    Penaud-Budloo, Magalie
    Bertil, Emilie
    Georger, Christophe
    Snyder, Richard
    Moullier, Philippe
    [J]. HUMAN GENE THERAPY, 2012, 23 (10) : A130 - A130